Arcadia Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Arcadia Biosciences using advanced sorting and filters.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
RKDA | Arcadia Biosciences | -$1.18 | -$0.54 | $0.63 | 216.67% | $1.54M | $1.90M | $1.30M | -31.47% | 11/07/2025 | |
RKDA | Arcadia Biosciences | $0.78 | — | -$3.26 | — | $1.31M | $1.60M | $1.46M | -9.06% | 08/14/2025 | |
RKDA | Arcadia Biosciences | -$1.78 | -$0.37 | $1.90 | 613.51% | $1.25M | $1.40M | $1.20M | -14.29% | 05/08/2025 | |
RKDA | Arcadia Biosciences | -$2.10 | -$0.89 | -$2.98 | -234.83% | $777.00K | $1.15M | $1.22M | 5.74% | 03/20/2025 | |
RKDA | Arcadia Biosciences | -$1.89 | -$0.81 | -$1.18 | -45.68% | $1.60M | $1.40M | $1.54M | 9.79% | 11/12/2024 | |
RKDA | Arcadia Biosciences | -$2.64 | $1.55 | $0.78 | -49.68% | $1.30M | $920.00K | $1.31M | 41.96% | 08/13/2024 | |
RKDA | Arcadia Biosciences | -$10.86 | -$2.21 | -$1.78 | 19.46% | $1.23M | $1.19M | $1.25M | 5.46% | 05/09/2024 | |
RKDA | Arcadia Biosciences | -$6.31 | -$2.58 | -$2.10 | 18.60% | $1.00M | $1.75M | $1.17M | -33.14% | 03/28/2024 | |
RKDA | Arcadia Biosciences | -$4.80 | -$3.19 | -$1.89 | 40.75% | $1.88M | $1.55M | $1.60M | 3.03% | 11/09/2023 | |
RKDA | Arcadia Biosciences | -$6.80 | -$4.80 | -$2.64 | 45.00% | $3.86M | $1.82M | $1.39M | -23.68% | 08/10/2023 | |
RKDA | Arcadia Biosciences | -$8.00 | -$6.85 | -$10.86 | -58.54% | $3.22M | $1.40M | $1.51M | 7.79% | 05/11/2023 | |
RKDA | Arcadia Biosciences | -$16.80 | -$6.80 | -$6.31 | 7.21% | $2.17M | $2.00M | $1.00M | -50.00% | 03/30/2023 | |
RKDA | Arcadia Biosciences | -$6.00 | -$8.40 | -$4.80 | 42.86% | $2.38M | $2.67M | $1.88M | -29.66% | 11/10/2022 | |
RKDA | Arcadia Biosciences | -$9.60 | -$9.20 | -$8.00 | 13.04% | $1.41M | $2.29M | $3.86M | 68.47% | 08/11/2022 | |
RKDA | Arcadia Biosciences | $4.40 | -$13.60 | -$8.00 | 41.18% | $828.00K | $1.90M | $3.22M | 69.47% | 05/12/2022 | |
RKDA | Arcadia Biosciences | $2.80 | -$12.00 | -$16.80 | -40.00% | $7.13M | $3.33M | $2.17M | -34.80% | 03/30/2022 | |
RKDA | Arcadia Biosciences | -$21.20 | -$11.60 | -$6.00 | 48.28% | $314.00K | $2.51M | $2.38M | -5.34% | 11/15/2021 | |
RKDA | Arcadia Biosciences | -$41.60 | -$10.80 | -$9.60 | 11.11% | $281.00K | $1.71M | $1.41M | -17.84% | 08/16/2021 | |
RKDA | Arcadia Biosciences | $11.60 | -$12.00 | $4.40 | 136.67% | $309.00K | $850.00K | $828.00K | -2.59% | 05/17/2021 | |
RKDA | Arcadia Biosciences | -$28.80 | -$16.40 | $2.80 | 117.07% | $416.00K | $1.26M | $7.13M | 465.87% | 03/30/2021 | |
RKDA | Arcadia Biosciences | -$81.60 | -$21.60 | -$21.20 | 1.85% | $392.00K | $1.14M | $314.00K | -72.46% | 11/12/2020 |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-07 | $0.63 | $-0.54 | 216.7 % |
| Q1 | 2025-05-08 | $1.90 | $-0.37 | 613.5 % |
| Q4 | 2025-03-20 | $-2.98 | $-0.89 | -234.8 % |
| Q3 | 2024-11-12 | $-1.18 | $-0.81 | -45.7 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-07 | $1.30M | $1.90M | -31.5 % |
| Q2 | 2025-08-14 | $1.46M | $1.60M | -9.06 % |
| Q1 | 2025-05-08 | $1.20M | $1.40M | -14.3 % |
| Q4 | 2025-03-20 | $1.22M | $1.15M | 5.74 % |
Arcadia Biosciences (RKDA) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2025 for Q3.
Arcadia Biosciences (RKDA) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2025 for Q3 and the Actual EPS was $0.63, which beat the estimate of $-0.54.
Arcadia Biosciences (RKDA) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2025 for Q3 and the Actual Revenue was $1.3M, which missed the estimate of $1.9M.
Browse earnings estimates, EPS, and revenue on all stocks.